SCHEMBL6837641

SCHEMBL6837641

FC(F)(F)c1nc2cc(Cl)ccc2c2c1nc(-c1ccccc1)n2CCN1CCNCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.42
KDM4E B2RXH2 4/20 0.38
LMNA P02545 2/20 0.38
KMT2A Q03164 2/20 0.38
S1PR2 O95136 1/20 0.38
HIF1A Q16665 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
PARP1 P09874 1/20 0.37
SMN1; SMN2 Q16637 3/20 0.36
ALDH1A1 P00352 3/20 0.36
TSHR P16473 2/20 0.36
HTR6 P50406 2/20 0.36
MAOB P27338 1/20 0.36
DRD2 P14416 2/20 0.35
HTR1A P08908 1/20 0.35
HTR7 P34969 1/20 0.35
CYP1A2 P05177 2/20 0.34
CYP3A4 P08684 2/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6833702 0.90 SLC6A2 (0.39) KDM4ESMN1; SMN2ALDH1A1TSHRHTR6
SCHEMBL6839980 0.90 ADRB2 (0.39) KDM4ELMNAKMT2ASMN1; SMN2ALDH1A1
SCHEMBL6838642 0.90 ALDH1A1 (0.45) KDM4EKMT2ASMN1; SMN2ALDH1A1TSHR
SCHEMBL6838576 0.88 KMT2A (0.33) LMNAKMT2APARP1HTR6MAOB
SCHEMBL6837686 0.86 EGFR (0.41) EGFRKDM4ELMNAKMT2AS1PR2
SCHEMBL6838565 0.86 HTR6 (0.42) KDM4ELMNAKMT2ANPSR1SMN1; SMN2
SCHEMBL6838072 0.86 HRH1 (0.35) KDM4ELMNAKMT2ANPSR1SMN1; SMN2
SCHEMBL6833788 0.85 ADRB2 (0.35) KMT2ACYP1A2CYP3A4CYP2D6ADRB2
SCHEMBL6838395 0.84 EIF4EBP1 (0.35) LMNAKMT2AHTR6CYP1A2CYP3A4
SCHEMBL6837812 0.82 EGFR (0.39) EGFRKDM4ELMNASMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040054182-A1 1h-imidazopyridine derivatives HOKURIKU SEIYAKU CO., LTD. (JP) 2004-03-18 US disclosed
EP-1256582-A1 1H-IMIDAZOPYRIDINE DERIVATIVES HOKURIKU SEIYAKU CO., LTD. (JP) 2002-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040054182-A1 1h-imidazopyridine derivatives IL2, IL1A, IL4 EGFR 1771/4885KDM4E 2253/4885LMNA 4507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.